Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ISRCTN10959031) titled 'Study with the IRIS System to investigate intra-uterine temperature and intra-uterine oxygen levels, and the impact of sildenafil' on July 3.
Study Type: Interventional
Study Design:
Multicenter feasibility non randomized trial (Other, Safety)
Primary Sponsor: Verso Biosense Limited
Condition:
Reproductive health
Urological and Genital Diseases
Intervention:
All participants would be enrolled into one of two groups (Group 1: Days 7-14 of the menstrual cycle, Group 2: Days 15-22 of the menstrual cycle) and will have the device implanted for 7 days. From Day 4 post insertion of the device, participant will ...